To ask the Secretary of State for Health what representations he has received asking for the Easyway to Stop Smoking programme to be assessed by the National Institute for Health and Clinical Excellence; and if he will make a statement.
The Department has received a number of representations on Allen Carr's Easyway, including requests for the National Institute for Health and Clinical Excellence (NICE) to undertake an appraisal of its clinical and cost effectiveness.
It is not within the remit of NICE to initiate or carry out clinical trials. NICE gives advice to the national health service on best clinical practice, including the clinical and cost effectiveness of drugs and the treatments based on published research. It would be for the Allen Carr Easyway organisation to make arrangements for clinical trials of their products to be undertaken.